{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:46:58Z","timestamp":1788922018197,"version":"build-2803163510"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>Central retinal artery occlusion (CRAO) is a rare and visually debilitating vascular condition characterized by sudden and severe vision loss. CRAO is a compelling target for intravenous alteplase (tPA) and endovascular mechanical thrombectomy (MT) due to pathophysiological similarities with acute ischemic stroke; however, the utility of these interventions in CRAO remains dubious due to limited sample sizes and potential risks. To assess usage and outcomes of tPA and MT in CRAO, we queried the National Inpatient Sample database using International Classification of Disease, Ninth and Tenth edition for patients with CRAO and acute ischemic stroke between 2010 and 2019. Our cohort of 5009 CRAO patients were younger with higher rates of obesity, hypertension, long-term anticoagulant use, and tobacco use compared to acute ischemic stroke patients. CRAO patients had lower rates of tPA administration (3.41% vs 6.21%) and endovascular MT (0.38% vs 1.31%) but fewer complications, including deep vein thrombosis, pneumonia, urinary tract infection, acute kidney injury, and acute myocardial infarction (all <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). CRAO patients had lower rates of poor functional outcome (31.74% vs 58.1%) and in-hospital mortality (1.2% vs 5.64%), but higher rates of profound blindness (9.24% vs 0.58%). A multivariate regression showed no relationship between tPA and MT and profound blindness, although the limited sample size of patients receiving interventions may have contributed to this apparent insignificance. Further investigation of larger patient cohorts and alternative treatment modalities could provide valuable insights for revascularization therapies in CRAO to optimize visual restoration and clinical outcomes.<\/jats:p>","DOI":"10.1097\/crd.0000000000000682","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T13:05:43Z","timestamp":1714136743000},"page":"291-296","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Nationwide Incidence and Trends in Central Retinal Arterial Occlusion Management: A 5000-Patient Analysis"],"prefix":"10.1097","volume":"32","author":[{"given":"Galadu","family":"Subah","sequence":"first","affiliation":[{"name":"From the Department of Neurosurgery, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Zeller","sequence":"additional","affiliation":[{"name":"From the Department of Neurosurgery, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Nolan","sequence":"additional","affiliation":[{"name":"School of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiden","family":"Lui","sequence":"additional","affiliation":[{"name":"School of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fortunato","sequence":"additional","affiliation":[{"name":"School of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Feldstein","sequence":"additional","affiliation":[{"name":"From the Department of Neurosurgery, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kafina","sequence":"additional","affiliation":[{"name":"Department of Neurology, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan R.","family":"Schloss","sequence":"additional","affiliation":[{"name":"CareMount Medical Neurology, Putnam Hospital, Carmel, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Elefant","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Westchester Medical Center, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Gandhi","sequence":"additional","affiliation":[{"name":"From the Department of Neurosurgery, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz","family":"Al-Mufti","sequence":"additional","affiliation":[{"name":"Department of Neurology, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"R1-20250619","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/WNO.0000000000001027","article-title":"Thrombolysis for central retinal artery occlusion in 2020: time is vision!","volume":"40","author":"Dumitrascu","year":"2020","journal-title":"J Neuroophthalmol"},{"key":"R3-20250619","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.3390\/jcm11216340","article-title":"Risk factors and treatment strategy for retinal vascular occlusive diseases.","volume":"11","author":"Terao","year":"2022","journal-title":"J Clin Med"},{"key":"R4-20250619","first-page":"235","article-title":"Treatment of nonarteritic acute central retinal artery occlusion.","volume":"7","author":"Sharma","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R5-20250619","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12886-018-0768-4","article-title":"Central retinal artery occlusion \u2013 rethinking retinal survival time.","volume":"18","author":"Tobalem","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"R6-20250619","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/STROKEAHA.119.027478","article-title":"Thrombolytic therapy for acute central retinal artery occlusion.","volume":"51","author":"Mac Grory","year":"2020","journal-title":"Stroke"},{"key":"R7-20250619","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/OPTH.S272126","article-title":"Intra-arterial tissue plasminogen activator for central retinal artery occlusion.","volume":"15","author":"Sobol","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"R8-20250619","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1161\/STROKEAHA.111.613653","article-title":"Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial.","volume":"42","author":"Chen","year":"2011","journal-title":"Stroke"},{"key":"R9-20250619","first-page":"101","article-title":"Intravenous thrombolytic therapy for acute nonarteritic central retinal artery occlusion. A review.","volume":"78","author":"Jansk\u00e1","year":"2022","journal-title":"Cesk Slov Oftalmol"},{"key":"R10-20250619","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","article-title":"Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis.","volume":"72","author":"Schrag","year":"2015","journal-title":"JAMA Neurol"},{"key":"R11-20250619","first-page":"17474930231189352","article-title":"Thrombolysis for central retinal artery occlusion: an individual participant-level meta-analysis.","volume":"19","author":"Shahjouei","year":"2023","journal-title":"Int J Stroke"},{"key":"R12-20250619","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00415-021-10838-6","article-title":"Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis.","volume":"269","author":"Huang","year":"2022","journal-title":"J Neurol"},{"key":"R13-20250619","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jama.2020.26867","article-title":"Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review.","volume":"325","author":"Mendelson","year":"2021","journal-title":"JAMA"},{"key":"R14-20250619","first-page":"e41878","article-title":"Intravenous thrombolysis for central retinal artery occlusion: a look at the literature for the emergency medicine physician.","volume":"15","author":"Webb","year":"2023","journal-title":"Cureus"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T16:01:45Z","timestamp":1750348905000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000682","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}